28
Views
25
CrossRef citations to date
0
Altmetric
Research Article

GB Virus C/Hepatitis G Virus

Pages 572-580 | Published online: 08 Jul 2009

References

  • Feinstone SM, Kapikian AZ, Purceli RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science 1973; 182: 1026–8.
  • Blumberg BS, Gerstley BJ, Hungerford DA, London WT, Sutnick AI. A serum antigen (Australia antigen) in Down’s syndrome, leukemia, and hepatitis. Ann Intern Med 1967; 66: 924–31.
  • Dane DS, Cameron CH, Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1970; 1: 695–8.
  • Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–4.
  • Rizzetto M, Canese MG, Arico S, Crivelli O, Trepo C, Bonino F, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977; 18: 997–1003.
  • Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983; 20: 23–31.
  • Deinhardt F, Holmes AW, Capps RB, Popper H. Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med 1967; 125: 673–88.
  • Muerhoff AS, Leary TP, Simons JN, Pilot-Matias TJ, Dawson GJ, Erker JC, et al. Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 1995; 69: 5621–30.
  • Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997; 241: 92–7.
  • Muerhoff AS, Leary TP, Desai SM, Mushahwar IK. Amplification and subtraction methods and their application to the discovery of novel human viruses. J Med Virol 1997; 53: 96–103.
  • Erker JC, Desai SM, Leary TP, Chalmers ML, Montes CC, Mushahwar IK. Genomic analysis of two GB virus A variants isolated from captive monkeys. J Gen Virol 1998; 79: 41–5.
  • Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1: 564–9.
  • Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505–8.
  • Muerhoff AS, Simons JN, Leary TP, Erker JC, Chalmers ML, Pilot-Matias TJ, et al. Sequence heterogeneity within the 5'-terminal region of the hepatitis GB virus C genome and evidence for genotypes. J Hepatol 1996; 25: 379–84.
  • Bukh J, Kim JP, Govindarajan S, Apgar CL, Foung SK, Wages J, et al. Experimental infection of chimpanzees with hepatitis G virus and genetic analysis of the virus. J Infect Dis 1998; 177: 855–62.
  • Birkenmeyer LG, Desai SM, Muerhoff AS, Leary TP, Simons JN, Montes CC, et al. Isolation of a GB virus-related genome from a chimpanzee. J Med Virol 1998; 56: 44–51.
  • Leary TP, Muerhoff AS, Simons JN, Pilotmatias TJ, Erker JC, Chalmers ML, et al. Sequence and genomic organization of GBV-C—a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996; 48: 60–7.
  • Schmolke S, Tacke M, Schmitt U, Engel AM, Ofenloch-Haehnle B. Identification of hepatitis G virus particles in human serum by E2-specific monoclonal antibodies generated by DNA immunization. J Virol 1998; 72: 4541–5.
  • Belyaev AS, Chong S, Novikov A, Kongpachith A, Masiarz FR, Lim M, et al. Hepatitis G virus encodes protease activities which can effect processing of the virus putative nonstructural proteins. J Virol 1998; 72: 868–72.
  • Laxton CD, McMillan D, Sullivan V, Ackrill AM. Expression and characterization of the hepatitis G virus helicase. J Viral Hepat 1998; 5: 21–6.
  • Xiang J, Daniels KJ, Soll DR, Schmidt WN, Labrecque DR, Stapleton JT. Visualization and characterization of GB virus-C particles: evidence for a nucleocapsid. J Viral Hepat 1999; 6 (Suppl 1): 16–22.
  • Okamoto H, Nakao H, Inoue T, Fukuda M, Kishimoto J, Iizuka H, et al. The entire nucleotide sequences of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan. J Gen Virol 1997; 78: 737–45.
  • Nakao H, Okamoto H, Fukuda M, Tsuda F, Mitsui T, Masuko K, et al. Mutation rate of GB virus C/hepatitis G virus over the entire genome and in subgenomic regions. Virology 1997; 233: 43–50.
  • Suzuki Y, Katayama K, Fukushi S, Kageyama T, Oya A, Okamura H, et al. Slow evolutionary rate of GB virus C/hepatitis G virus. J Mol Evol 1999; 48: 383–9.
  • Mukaide M, Mizokami M, Orito E, Ohba K, Nakano T, Ueda R, et al. Three different GB virus C/hepatitis G virus genotypes. Phylogenetic analysis and a genotyping assay based on restriction fragment length polymorphism. FEBS Lett 1997; 407: 51–8.
  • Smith DB, Basaras M, Frost S, Haydon D, Cuceanu N, Prescott L, et al. Phylogenetic analysis of GBV-C/hepatitis G virus. J Gen Virol 2000; 3: 769–80.
  • Tanaka Y, Mizokami M, Orito E, Ohba K, Nakano T, Kato T, et al. GB virus C/hepatitis G virus infection among Colombian native Indians. Am J Trop Med Hyg 1998; 59: 462–7.
  • Tanaka Y, Mizokami M, Orito E, Ohba K, Kato T, Kondo Y, et al. African origin of GB virus C/hepatitis G virus. FEBS Lett 1998; 423: 143–8.
  • Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludlam CA, Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352–5.
  • Kao JH, Chen PJ, Chen W, Hsiang SC, Lai MY, Chen DS. Amplification of GB virus-C/hepatitis G virus RNA with primers from different regions of the viral genome. J Med Virol 1997; 51: 284–9.
  • Lara C, Halasz R, Sönnerborg A, Sällberg M. Detection of hepatitis G virus RNA in persons with and without known risk factors for blood borne viral infections in Sweden and Honduras. J Clin Microbiol 1998; 36: 255–7.
  • Chen M, Fischler B, Hultgren C, Halasz R, Nemeth A, Sallberg M. Analysis of GB virus C markers in families over three generations. J Clin Microbiol 1999; 37: 4153–5.
  • Pilotmatias TJ, Muerhoff AS, Simons JN, Leary TP, Buijk SL, Chalmers ML, et al. Identification of antigenic regions in the GB hepatitis viruses GBV-A, GBV-B, and GBV-C. J Med Virol 1996; 48: 329–38.
  • Pilotmatias TJ, Carrick RJ, Coleman PF, Leary TP, Surowy TK, Simons JN, et al. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology 1996; 225: 282–92.
  • Dille BJ, Surowy TK, Gutierrez RA, Coleman PF, Knigge MF, Carrick RJ, et al. An Elisa for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 1997; 175: 458–61.
  • Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch +++haehnle B, Hess G, et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349: 318–20.
  • Tacke M, Schmolke S, Schlueter V, Sauleda S, Esteban JI, Tanaka E, et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997; 26: 1626–33.
  • Hassoba HM, Terrault NA, el-Gohary AM, Scheffel C, Jou C, Brackett J, et al. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity? J Med Virol 1997; 53: 354–60.
  • Lazdina U, Hultgren C, Chen M, Fischler B, Weiland O, Mushahwar IK, et al. Humoral and cellular immune responses to the GB virus C hepatitis G virus envelope 2 protein. J Med Virol 2000; 62: 334–44.
  • Feucht HH, Zollner B, Polywka S, Knodler B, Schroter M, Nolte H, et al. Prevalence of hepatitis G viremia among healthy subjects, individuals with liver disease, and persons at risk for parenteral transmission. J Clin Microbiol 1997; 35: 767–8.
  • Brown KE, Wong S, Buu M, Binh TV, Be TV, Young NS. High prevalence of GB virus C hepatitis G virus in healthy persons in Ho Chi Minh City, Vietnam. J Infect Dis 1997; 175: 450–3.
  • Lampe E, Saback FL, Viazov S, Roggendorf M, Niel C. Age-specific prevalence and genetic diversity of GBV-C/hepatitis G virus in Brazil. J Med Virol 1998; 56: 39–43.
  • El-Zayadi AR, Abe K, Selim O, Naito H, Hess G, Ahdy A. Prevalence of GBV-C/hepatitis G virus viraemia among blood donors, health care personnel, chronic non-B non-C hepatitis, chronic hepatitis C and hemodialysis patients in Egypt. J Virol Methods 1999; 80: 53–8.
  • Dawson GJ, Schlauder GG, Pilotmatias TJ, Thiele D, Leary TP, Murphy P, et al. Prevalence studies of GB virus-C infection using reverse transcriptase polymerase chain reaction. J Med Virol 1996; 50: 97–103.
  • Ross RS, Viazov S, Schmitt U, Schmolke S, Tacke M, Ofenloch-Haehnle B, et al. Distinct prevalence of antibodies to the E2 protein of GB virus C/hepatitis G virus in different parts of the world. J Med Virol 1998; 54: 103–6.
  • Bjorkman P, Sundstrom G, Widell A. Hepatitis C virus and GB virus C hepatitis G virus viremia in Swedish blood donors with different alanine aminotransferase levels. Transfusion 1998; 38: 378–84.
  • Halasz R, Fischler B, Nemeth A, Lundholm S, Sällberg M. A high prevalence of serum GB virus type C/hepatitis G virus RNA in children with and without liver disease. Clin Inf Dis 1999; 28: 537–40.
  • Halasz R, Sallberg M, Lundholm S, Andersson G, Lager B, Glaumann H, et al. The GB virus C/hepatitis B virus replicates in hepatocytes without causing liver disease in healthy blood donors. J Infect Dis 2000; 182: 1756–60.
  • Nordbo SA, Krokstad S, Winge P, Skjeldestad FE, Dalen AB. Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors. J Clin Microbiol 2000; 38: 2584–90.
  • Love A, Stanzeit B, Gudmundsson S, Widell A. Hepatitis G virus infections in Iceland. J Viral Hepat 1999; 6: 255–60.
  • Halasz R, Barkholt L, Lara C, Hultgren C, Ando Y, Broom U, et al. Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products. Gut 1999; 44: 274–8.
  • Anastassopoulou CG, Paraskevis D, Sypsa V, Psichogiou M, Katsoulidou A, Tassopoulos N, et al. Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users. J Med Virol 1998; 56: 246–52.
  • de Martino M, Azzari C, Resti M, Moriondo M, Rossi ME, Galli L, et al. Hepatitis G virus infection in human immunodeficiency virus type 1-infected mothers and their children. J Infect Dis 1998; 178: 862–5.
  • Fischler B, Lara C, Chen M, Sönnerborg A, Nemeth A, Sällberg M. Genetic evidence for mother-to-infant transmission of hepatitis G (GBV-C) virus. J Inf Dis 1997; 176: 281–5.
  • Wejstal R, Manson AS, Widell A, Norkrans G. Perinatal transmission of hepatitis G virus (GB virus type C) and hepatitis C virus infections—a comparison. Clin Infect Dis 1999; 28: 816–21.
  • Sarrazin C, Roth WK, Zeuzem S. Heterosexual transmission of GB virus-C/hepatitis G virus infection. Eur J Gastroenterol Hepatol 1997; 9: 1117–20.
  • Scallan MF, Clutterbuck D, Jarvis LM, Scott GR, Simmonds P. Sexual transmission of GB virus C/hepatitis G virus. J Med Virol 1998; 55: 203–8.
  • Semprini AE, Persico T, Thiers V, Oneta M, Tuveri R, Serafini P, et al. Absence of hepatitis C virus and detection of hepatitis G virus/GB virus C RNA sequences in the semen of infected men. J Infect Dis 1998; 177: 848–54.
  • Chen M, Sonnerborg A, B. J, Sällberg M. Detection of hepatitis G (or GB Virus C) RNA in human saliva. J Clin Microbiol 1997; 35: 973–5.
  • Viazov S, Riffelmann M, Sarr S, Ballauff A, Meisel H, Roggendorf M. Transmission of GBV-C/HGV from drug-addicted mothers to their babies. J Hepatol 1997; 27: 85–90.
  • Hino K, Moriya T, Ohno N, Takahashi K, Hoshino H, Ishiyama N, et al. Mother-to-infant transmission occurs more frequently with GB virus C than hepatitis C virus. Arch Virol 1998; 143: 65–72.
  • Zanetti AR, Tanzi E, Romano L, Principi N, Zuin G, Minola E, et al. Multicenter trial on mother-to-infant transmission of GBV-C virus. J Med Virol 1998; 54: 107–12.
  • Lau JY, Qian K, Detmer J, Collins ML, Orito E, Kolberg JA, et al. Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV. J Infect Dis 1997; 176: 421–6.
  • Martinot M, Marcellin P, Boyer N, Detmer J, Pouteau M, Castelnau C, et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C [see comments]. Ann Intern Med 1997; 126: 874–81.
  • Lefrere JJ, Roudot-Thoraval F, Morand-Joubert L, Brossard Y, Parnet-Mathieu F, Mariotti M, et al. Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: evidence of sexual and parenteral transmission. Transfusion 1999; 39: 83–94.
  • Woelfle J, Berg T, Keller KM, Schreier E, Lentze MJ. Persistent hepatitis G virus infection after neonatal transfusion. J Pediatr Gastroenterol Nutr 1998; 26: 402–7.
  • Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis [see comments]. N Engl J Med 1996; 334: 1485–90.
  • Mushahwar IK, Zuckerman JN. Clinical implications of GB virus C. J Med Virol 1998; 56: 1–3.
  • Stark K, Bienzle U, Hess G, Engel AM, Hegenscheid B, Schluter W. Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996; 174: 1320–3.
  • Fogeda M, Navas S, Martin J, Casqueiro M, Rodriguez E, Arocena C, et al. In vitro infection of human peripheral blood mononuclear cells by GB virus C/hepatitis G virus. J Virol 1999; 73: 4052–61.
  • Kobayashi M, Tanaka E, Nakayama J, Furuwatari C, Katsuyama T, Kawasaki S, et al. Detection of GB virus-C/hepatitis G virus genome in peripheral blood mononuclear cells and liver tissue. J Med Virol 1999; 57: 114–21.
  • Handa A, Brown KE. GB virus C/hepatitis G virus replicates in human haematopoietic cells and vascular endothelial cells. J Gen Virol 2000; 81: 2461–9.
  • Kao JH, Chen W, Chen PJ, Lai MY, Chen DS. Liver and peripheral blood mononuclear cells are not major sites for GB virus-C/hepatitis G virus replication. Arch Virol 1999; 144: 2173–83.
  • Saito S, Tanaka K, Kondo M, Morita K, Kitamura T, Kiba T, et al. Plus- and minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells. Biochem Biophys Res Commun 1997; 237: 288–91.
  • Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol 1997; 71: 7804–6.
  • Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Detection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR. J Virol 1998; 72: 3072–5.
  • Laras A, Zacharakis G, Hadziyannis SJ. Absence of the negative strand of GBV-C/HGV RNA from the liver. J Hepatol 1999; 30: 383–8.
  • Tucker TJ, Smuts HE, Eedes C, Knobel GD, Eickhaus P, Robson SC, et al. Evidence that the GBV-C/hepatitis G virus is primarily a lymphotropic virus. J Med Virol 2000; 61: 52–8.
  • Tanaka E. Does GBV-C/HGV replicate in the liver? [Editorial]. J Gastroenterol 1999; 34: 721–3.
  • Seipp S, Scheidel M, Hofmann WJ, Tox U, Theilmann L, Goeser T, et al. Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines. J Hepatol 1999; 30: 570–9.
  • Fan X, Xu Y, Solomon H, Ramrakhiani S, Neuschwander-Tetri BA, Di Bisceglie AM. Is hepatitis G/GB virus-C virus hepatotropic? Detection of hepatitis G/GB virus-C viral RNA in liver and serum. J Med Virol 1999; 58: 160–4.
  • Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology [see comments]. Lancet 1995; 346: 1131–2.
  • Tameda Y, Kosaka Y, Tagawa S, Takase K, Sawada N, Nakao H, et al. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. J Hepatol 1996; 25: 842–7.
  • Bjorkman P, Sundstrom G, Veress B, Widell A. Assessment of liver disease and biochemical and immunological markers in Swedish blood donors with isolated GB virus C/hepatitis G virus viremia. Vox Sang 2000; 78: 143–8.
  • Handa A, Jubran RF, Dickstein B, Boylan A, Luban NL, Young NS, et al. GB virus C/Hepatitis G virus infection is frequent in American children and young adults. Clin Infect Dis 2000; 30 : 569–71.
  • Lai MW, Chang MH, Hsu HY. Non-A, non-B, non-C hepatitis: its significance in pediatric patients and the role of GB virus-C [see comments]. J Pediatr 1997; 131: 536–40.
  • Fiordalisi G, Zanella I, Mantero G, Bettinardi A, Stellini R, Paraninfo G, et al. High prevalence of GB virus C infection in a group of Italian patients with hepatitis of unknown etiology. J Infect Dis 1996; 174: 181–3.
  • Romano L, Fabris P, Tanzi E, Tositti G, Mazzotta F, Zanetti AR. GBV-C/hepatitis G virus in acute nonA-E hepatitis and in acute hepatitis of defined aetiology in Italy. J Med Virol 2000; 61: 59–64.
  • Alter MJ, Gallagher M, Morris TT, Moyer LA, Meeks EL, Krawczynski K, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team [see comments]. N Engl J Med 1997; 336: 741–6.
  • Moaven LD, Locarnini SA, Bowden DS, Kim JP, Breschkin A, McCaw R, et al. Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection. J Hepatol 1997; 27: 613–9.
  • Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Boker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GB virus C. Lancet 1996; 348: 1626–9.
  • Haydon GH, Jarvis LM, Simpson KJ, Hayes PC, Simmonds P. The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant, presumed viral, hepatitis. J Viral Hepat 1997; 4: 45–9.
  • Kanda T, Yokosuka O, Ehata T, Maru Y, Imazeki F, Saisho H, et al. Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction. Hepatology 1997; 25: 1261–5.
  • Karayiannis P, Thomas HC. Hepatitis G virus: identification, prevalence and unanswered questions. Gut 1997; 40: 294–6.
  • Bralet MP, Roudotthoraval F, Pawlotsky JM, Bastie A, Vannhieu JT, Duval J, et al. Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroenterology 1997; 112: 188–92.
  • Shev S, Bjorkman P, Norkrans G, Foberg U, Fryden A, Lindh G, et al. GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donors. J Med Virol 1998; 54: 75–9.
  • Zampino R, Pickering J, Iqbal M, Gaud U, Thomas HC, Karayiannis P. Hepatitis G virus/GBV-C persistence: absence of hypervariable E2 region and genetic analysis of viral quasispecies in serum and lymphocytes. J Viral Hepat 1999; 6: 209–18.
  • Muller C, Pfeffel F, Peck-Radosavljevic M, Petermann D, Oesterreicher C, Pidlich J. Prevalence of hepatitis G virus in patients with hepatocellular carcinoma. J Viral Hepat 1997; 4: 411–4.
  • Brechot C, Jaffredo F, Lagorce D, Gerken G, Meyer zum Buschenfelde K, Papakonstontinou A, et al. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action [published erratum appears in J Hepatol 1998; 29: 686]. J Hepatol 1998; 29: 173–83.
  • Abe K, Edamoto Y, Park YN, Nomura AM, Taltavull TC, Tani M, et al. In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology 1998; 28: 568–72.
  • Yuan JM, Govindarajan S, Ross RK, Yu MC. Chronic infection with hepatitis G virus in relation to hepatocellular carcinoma among non-Asians in Los Angeles County, California. Cancer 1999; 86: 936–43.
  • Hayashi J, Ueno K, Kawakami Y, Kishihara Y, Ariyama I, Furusyo N, et al. Clinical course of chronic hepatitis C virus infection is not influenced by concurrent hepatitis G virus infection. Dig Dis Sci 1999; 44: 618–23.
  • Colombo M. Hepatitis C virus and hepatocellular carcinoma. Semin Liver Dis 1999; 19: 263–9.
  • Ljungman P, Halasz R, Hagglund H, Sonnerborg A, Ringden O. Detection of hepatitis G virus/GB virus C after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 22 : 499–501.
  • Bonacini M, Qian D, Govindarajan S, Valinluck B. Prevalence of hepatitis G virus RNA in the sera of patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 40–3.
  • Zaidi Y, Chapman CS, Myint S. Aplastic anaemia after HGV infection [Letter] [see comments]. Lancet 1996; 348: 471–2.
  • Moriyama K, Okamura T, Nakano S. Hepatitis GB virus C genome in the serum of aplastic anaemia patients receiving frequent blood transfusions [see comments]. Br J Haematol 1997; 96: 864–7.
  • Brown KE, Wong S, Young NS. Prevalence of GBV-C/HGV, a novel ‘hepatitis’ virus, in patients with aplastic anaemia. Br J Haematol 1997; 97: 492–6.
  • Rodriguez-Inigo E, Tomas JF, Gomez-Garcia de Soria V, Bartolome J, Pinilla I, Amaro MJ, et al. Hepatitis C and G virus infection and liver dysfunction after allogeneic bone marrow transplantation: results from a prospective study. Blood 1997; 90: 1326–31.
  • Bizollon T, Guichard S, Ahmed SN, Chevallier P, Ducerf C, Sepetjan M, et al. Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation. J Hepatol 1998; 29: 893–900.
  • Vargas HE, Laskus T, Radkowski M, Poutous A, Wang LF, Lee R, et al. Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients. Transplantation 1997; 64: 786–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.